What class of antiarrhythmic drugs blocks potassium channels prolonging phase 3 of the action potential and slowing the rate and conduction of the heart?
I.
IV.
III.
II.
The Correct Answer is C
Choice A rationale
Class I antiarrhythmic drugs block sodium channels, affecting phase 0 of the action potential, not phase 3.
Choice B rationale
Class IV antiarrhythmic drugs block calcium channels, which affects phase 2 of the action potential and slows heart rate and conduction.
Choice C rationale
Class III antiarrhythmic drugs block potassium channels, prolonging phase 3 of the action potential. This results in a prolonged repolarization period, reducing the risk of arrhythmia.
Choice D rationale
Class II antiarrhythmic drugs are beta-blockers that primarily affect phase 4 of the action potential, reducing heart rate and conduction, but they do not block potassium channels.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
Choice A rationale
Ergotamine does not increase hypoperfusion. It is used to constrict blood vessels to reduce blood flow.
Choice B rationale
Ergotamine does not decrease hypoperfusion. It is used to constrict blood vessels to reduce blood flow.
Choice C rationale
Ergotamine does not increase hyperperfusion. It is used to constrict blood vessels to reduce blood flow.
Choice D rationale
Ergotamine decreases hyperperfusion by constricting blood vessels in the basilar artery vascular bed, reducing the blood flow to relieve migraine headaches. .
Correct Answer is A
Explanation
Choice A rationale
Asking the patient what time of day the medication is taken can help identify if taking it at a different time might alleviate sleep disturbances. SSRIs like sertraline can cause insomnia if taken later in the day.
Choice B rationale
Recommending a weekly dosage is inappropriate and could potentially disrupt the therapeutic effect. SSRIs should be taken daily, as prescribed.
Choice C rationale
Counseling the patient to take the medication at bedtime could worsen sleep disturbances, as sertraline may cause insomnia in some individuals. Timing should be adjusted based on patient response.
Choice D rationale
Suggesting a lower dose without consulting the provider may not address the issue effectively and could reduce the efficacy of the medication. Dosage adjustments should be made based on clinical assessment and provider recommendation.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.